Publications – Center for Communicable Disease Dynamics

Enterobacteriaceae isolated from patients share antibiotic resistance conferring plasmids recently acquired from those isolated from sinks in the same treatment room

Author(s): Taylor BP, Che Y, Passarelli H, Smollan G, Cohen C, Rapaport R, Tal I, Zade NP, Jaber H, Keller N, Hanage WP, Regev-Yochay GJournal: bioRxiv November 2022

Identifying how and where pathogens acquire antibiotic resistance is crucial to developing effective strategies to limit its spread. Many bacterial…

Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa.

Author(s): Reichert E, Schaeffer B, Gantt S, Rumpler E, Govender N, Welch R, Shonhiwa AM, Iwu CD, Lamola TM, Moema-Matiea I, Muganhiri D, Hanage W, Santillana M, Jassat W, Cohen C, Swerdlow DJournal: Lancet MicrobePMID: 36057266 August 2022

Assessment of disease severity associated with a novel pathogen or variant provides crucial information needed by public health agencies and…

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.

Author(s): Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, Reis BY, Balicer RDJournal: LancetPMID: 34756184 October 2021

Many countries are experiencing a resurgence of COVID-19, driven predominantly by the delta (B.1.617.2) variant of SARS-CoV-2. In response, these…

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel.

Author(s): Regev-Yochay G, Amit S, Bergwerk M, Lipsitch M, Leshem E, Kahn R, Lustig Y, Cohen C, Doolman R, Ziv A, Novikov I, Rubin C, Gimpelevich I, Huppert A, Rahav G, Afek A, Kreiss YJournal: Lancet Reg Health EurPMID: 34250518 August 2021

BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on…

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.

Author(s): Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Gal Levin E, Rubin C, Indenbaum V, Tal I, Zavitan M, Zuckerman N, Bar-Chaim A, Kreiss Y, Regev-Yochay GJournal: N Engl J MedPMID: 34320281 July 2021

Despite the high efficacy of the BNT162b2 messenger RNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rare breakthrough…